首页> 外文期刊>International Journal of Applied Research in Veterinary Medicine >In vitro Evaluation of ABCBI After Exposure to Prednisolone and Enrofloxacin in Two Canine Lymphoid Cell Lines: A Pilot Study
【24h】

In vitro Evaluation of ABCBI After Exposure to Prednisolone and Enrofloxacin in Two Canine Lymphoid Cell Lines: A Pilot Study

机译:两种犬淋巴样细胞系中泼尼松龙和恩诺沙星暴露后的ABCBI体外评估:一项初步研究。

获取原文
获取原文并翻译 | 示例
       

摘要

Multidrug resistance (MDR), a common cause of chemotherapeutic failure, is associated with the expression of P-glycoprotein (P-gp), encoded for by ABCBl, the multidrug resistance gene. Our purpose was to determine whether ABCBl expression is expressedafter exposure of two canine lymphoid cell lines to prednisolone or enrofloxacin. Two established lymphoid cell lines (GL-1, 17-71) were cultured for 14 days, during which cell lines were exposed to drug concentrations equivalent to clinically relevantdoses of either prednisolone or enrofloxacin. RNA was extracted from cultured cells and RT-PCR was performed to evaluate ABCBI expression. No ABCBI expression was detected in either lymphoid cell line with exposure to prednisolone or enrofloxacin. The ABCBI gene does not appear to be upregulated using these drugs in these cell lines in the time frame examined. Pretreatment with corticosteroids prior to chemotherapeutic administration may not induce ABCBI drug resistance in canine lymphoid cells as has been reported.
机译:多药耐药性(MDR)是化疗失败的常见原因,它与多药耐药基因ABCB1编码的P-糖蛋白(P-gp)的表达有关。我们的目的是确定两种犬淋巴样细胞系暴露于泼尼松龙或恩诺沙星后是否表达ABCB1。将两种已建立的淋巴样细胞系(GL-1、17-71)培养14天,在此期间,将细胞系暴露于与泼尼松龙或恩诺沙星的临床相关剂量相当的药物浓度。从培养的细胞中提取RNA,并进行RT-PCR以评估ABCBI表达。暴露于泼尼松龙或恩诺沙星的淋巴样细胞系中均未检测到ABCBI表达。在检查的时间范围内,在这些细胞系中使用这些药物似乎并未上调ABCBI基因。如已报道的,在化学治疗之前用皮质类固醇进行预处理可能不会在犬淋巴样细胞中诱导ABCBI耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号